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Boom or Bust?*Pamela S. Douglas, MDSEE PAGE 690B ecause the growth in utilization of cardiovas-cular (CV) imaging since the 1990s has beenso well documented and the ﬁndings so consis-
tent, there is a general assumption that imaging is
overused. Quality improvement efforts in imaging
have become nearly synonymous with efforts to
reduce use, whether they are appropriate use criteria
(AUC), payer constraints on testing access, or the
“Choose Wisely” campaign. Although imagers have
countered with a call to emphasize value rather than
volume, the message is still essentially the same: do
less. These efforts have been successful with a
“bending of the curve” of CV imaging growth begin-
ning in 2008 (1). However, by limiting quality efforts
to overuse, we ignore the very important possibility
that underuse and misuse can also occur. Further,
although overuse may result in a relatively harmless
collection of redundant information, underuse may
be associated with a failure to acquire critical in-
formation and diagnose and treat signiﬁcant disease,
arguably a more important concern. Worse, the efforts
to reduce all imaging use could have the unintended
consequence of reducing needed imaging, exacer-
bating the problem of underuse.
So, is there evidence of underuse in CV imaging?
This is a difﬁcult question to answer. AUC and
guidelines generally do not address underuse, and
there are few clinical scenarios in which a national
standard calls for “must do” imaging. Further imaging
occurs early in the process of symptom evaluation so
that information about the number, characteristics,
and outcomes of those who are not imaged is un-
available. Nevertheless, there are clues that imaging
is, in fact, underutilized in some scenarios. Current
AUC suggests that use of diagnostic catheterization
and revascularization should be preceded by docu-
mentation of ischemia in most cases (2). In practice,* Editorials published in JACC: Cardiovascular Imaging reﬂect the views of
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tive diagnostic catheterizations in subjects without
prior coronary artery disease did not have a preceding
noninvasive test for ischemia, and Lin et al. (4) noted
that only 44.5% of those undergoing elective angio-
plasty had a prior stress test. However, in both of
these scenarios, there can be compelling reasons to
proceed directly to an invasive procedure.
In contrast, the evaluation of systolic performance
in patients with incident heart failure is a “must do”
imaging indication, supported as 1 of just 5 perfor-
mance measures for inpatients in the initial heart
failure set from 2005 (the others are: use of
angiotensin-converting enzyme inhibitors or angio-
tensin receptor blockers, anticoagulants in atrial
ﬁbrillation, smoking cessation, and discharge instruc-
tions) and 1 of 11 measures for outpatients (5). We
previously used Medicare data to report limited
adherence to this quality metric, with the prevalence
of left ventricular function assessment increasing
from 46% in 1995 to 60% in 2007 (6). At 79%, in-
patients were nearly 4-fold more likely to be tested
than outpatients in 2007. In this issue of iJACC,
Farmer et al. (7) conﬁrmed these data in a clinical
trial population embedded in integrated delivery
systems, and found a very similar prevalence of
systolic function assessment of 73% during the same
time period (2005 to 2008). Taken together, these 2
papers provide strong evidence in separate but large
populations that CV imaging is indeed underutilized
in roughly one-quarter of patients in an important
and common clinical scenario. Quality efforts in im-
aging should recognize this gap; we can no longer
focus exclusively on overuse and ignore underuse if
we are truly striving to improve imaging care.The data from Farmer et al. (7) also conﬁrm prior
studies that found marked variability in imaging
use among hospitals. Lin et al. (4) noted that pre-
percutaneous coronary intervention (PCI) stress tes-
ting rates ranged from 22.1% to 70.6% among the
hospital referral regions; we have noted that 656
hospitals’ use of stress testing in the ﬁrst year after PCI
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702ranged from 8.6% to 66.0% (8). Curtis et al. (6) did not
compare testing rates by institution but did ﬁnd 28%
higher use of testing in the northeast as comparedwith
the western United States. These ﬁndings conﬁrm a
quality gap. They also provide a natural experiment in
which to examine outcomes. Does greater testing lead
to better outcomes, as it should if there is underuse?
The study by Farmer et al. (7) unfortunately did not
provide outcomes and so it cannot address this issue;
however, Curtis et al. (6) noted a 12% lower 1-year
mortality rate among those who received a left ven-
tricular function assessment compared with those
who did not (hazard ratio: 0.88, 95% conﬁdence in-
terval: 0.86 to 0.91). Lin et al. (9) noted a 13% lower risk
of death over 3.4 years in those who underwent pre-
PCI stress (hazard ratio: 0.87; 95% conﬁdence inter-
val: 0.81 to 0.92). Although it is impossible to ascribe
these differences to imaging per se, especially because
its use is probably a marker for higher quality in other
aspects of care, they do suggest that underuse of
imaging can be dangerous to your patients’ health.
There are several other important pieces of data
presented that would be useful in designing quality
improvement efforts. Farmer et al. (7) note that a
failure to image was associated with advancing age,
female sex, and other illnesses such as acute myocar-
dial infarction and stroke. Curtis et al. (6) also found
less imaging in older, sicker patients and women.
These results are not surprising, as many authors have
documented worse adherence to standards of care in
these groups; however, they provide clues to which
groups could be targeted in quality improvement ef-
forts. Farmer et al. (7) also noted lower echocardiog-
raphy use in patients with conditions that wouldnormally be associated with a higher propensity to
image, including atrial ﬁbrillation and valvular heart
disease; this raises the question of whether some
testing use was not accurately captured. Indeed, the
ﬁnding by Curtis et al. (6) that widening the window
from 30 to 365 days increased testing prevalence by
8% for inpatients and 77% for outpatients suggests
that a 14-day pre-admission window is too narrow to
accurately detect the availability of information
regarding systolic function, which is, of course, the
goal rather than imaging use per se.
Other important data are still missing. Both of these
reports are on the basis of claims data, and neither
includes robust clinical information; the lack of a na-
tional imaging registry is a missed opportunity that
would immeasurably help quality assessment efforts.
For example, at present, the use ofmultiple tests can be
documented (6,7), but their utility cannot be addressed
without knowing testing indications or results. Simi-
larly, the impact of ongoing changes in healthcare
delivery, such as point-of-care decision support tools,
accountable care organizations, and electronicmedical
records, which provide not only reports but actual
images for review, cannot be assessed. Similarly, the
potential impact of implementing imaging quality
metrics using already established methodology is un-
known, as none have yet been developed (10). Never-
theless, the time has come to address the entirety of
imaging utilization if we are to improve imaging care.
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